OTCMKTS:TGXSF

Tigenix (TGXSF) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$2.04
$2.04
50-Day Range
N/A
52-Week Range
$1.02
$2.14
Volume
20 shs
Average Volume
8,248 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Tigenix

TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium.

TGXSF Stock News Headlines

TIG_old Historical Data
See More Headlines
Receive TGXSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tigenix and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Specialties
Sub-Industry
N/A
Current Symbol
OTCMKTS:TGXSF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:TGXSF) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners